[Therapeutic effect of a new molecule, epomediol, in intrahepatic cholestasis].
D019086:Bridged Bicyclo Compounds, Heterocyclic; D002756:Cholagogues and Choleretics / Q000627:therapeutic use*; D002780:Cholestasis, Intrahepatic / Q000188:drug therapy* / Q000209:etiology; D002784:Cholesterol / Q000097:blood; D004798:Enzymes / Q000097:blood; D006505:Hepatitis / Q000150:complications; D006801:Humans; D008074:Lipoproteins / Q000097:blood; D008103:Liver Cirrhosis / Q000150:complications; D011517:Prothrombin Time; D013729:Terpenes / Q000627:therapeutic use*
D019086:Bridged Bicyclo Compounds, Heterocyclic; D002756:Cholagogues and Choleretics; D004798:Enzymes; D008074:Lipoproteins; D013729:Terpenes; D002784:Cholesterol; C031365:epomediol
Studio dell'effetto terapeutico di una nuova molecola, l'epomediol, nella colestasi intraepatica.